Rafi, I, Crinson, I, Dawes, M, Rafi, D, Pirmohamed, M 
ORCID: 0000-0002-7534-7266 and Walter, FM
(2020)
The implementation of pharmacogenomics into UK general practice: a qualitative study exploring barriers, challenges and opportunities.
JOURNAL OF COMMUNITY GENETICS, 11 (3).
pp. 269-277.
|
Text
The implementation of pharmacogenomics into UK general practice a qualitative study exploring barriers, challenges and oppor.pdf - Published Version Download (305kB) | Preview |
Abstract
Pharmacogenomics describes interpatient genetic variability in drug responses. Information based on whole genome sequencing will soon open up the field of pharmacogenomics and facilitate the use of genomic information relating to drug metabolism and drug responses. We undertook a qualitative study, aiming to explore the potential barriers, opportunities and challenges facing the implementation of pharmacogenomics into primary care. Semi-structured interviews were undertaken with 18 clinical participants (16 GPs and 2 other clinicians). All interviews were recorded and transcribed verbatim. Using a thematic analysis approach, data items were coded, ordered and themes constructed. Most participants were aged 55-60 years and worked as part-time clinical GPs with other clearly defined roles. The emerging themes covered several areas of concern, including the following: the utility of pharmacogenomics and the value of introducing such testing into primary care; how to educate the primary care workforce and 'mainstream' pharmacogenomics; the ethical, legal and social aspects of pharmacogenomics and its impact on patients; and potential impacts on the healthcare system particularly around economics and informatics. Most participants had concerns about pharmacogenomics and felt that there were a number of barriers and challenges to its implementation into routine primary care. Most striking were their concerns around the cost-effectiveness of using pharmacogenomics in primary care. At the same time most recognised the increasing availability of direct-to-consumer testing, and felt that this would drive the need to understand the ethical and social implications of using genomic information in primary care. This study has raised important issues that need to be considered when planning the implementation of pharmacogenomics into clinical practice. Prior to the implementation of genomic testing into day-to-day practice in UK primary care, it is important that considerations around education, cost-effectiveness and informatics are addressed, as well as the impact on patients.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Health Services, Human Genome, Clinical Research, Genetics, Patient Safety, 8 Health and social care services research, 8.1 Organisation and delivery of services, 3 Good Health and Well Being |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 08 Sep 2020 15:55 |
| Last Modified: | 15 Mar 2024 06:26 |
| DOI: | 10.1007/s12687-020-00468-2 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3100415 |
Dimensions
Dimensions
